Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, reflecting a minor update to the page. This is a metadata/version update and does not alter the study data or eligibility details shown on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.3 replaces v3.6.0 on the page, indicating a backend update to the study page. This change primarily concerns the page’s versioning and metadata rather than the study content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now shows a recruitment status note indicating enrollment has ended for this Fabry disease study. It also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and includes a minor formatting/version update (Intervention/Treatment heading and Revision: v3.6.0).SummaryDifference0.4%

- Check50 days agoChange DetectedThe revision tag on the page updated from v3.5.4 to v3.5.5, signaling a new page revision. The change is a metadata/version update and does not modify the study details shown.SummaryDifference0.0%

- Check71 days agoChange DetectedA new Genet Med 2021 publication about migalastat-treated Fabry disease was added to the Publications list, and the revision tag was updated to v3.5.4, replacing the prior v3.5.3 entry that included an Erratum.SummaryDifference0.1%

- Check93 days agoChange DetectedThis page’s footer revision label was updated from “v3.5.2” to “v3.5.3.” This represents a system/version update rather than a change to the study record content.SummaryDifference0.0%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.